A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1997
11/04/1997	US5683695 Production of recombinant proteins containing multiple antigenic determinants linked by flexible hinge domains
11/04/1997	US5683693 Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
11/04/1997	CA2175719A1 Compositions and methods for protection against immunologically diverse isolates of influenza virus
11/04/1997	CA1339526C Recombinant myco-bacterial expression vehicles and uses therefor
10/1997
10/30/1997	WO1997040182A1 Genetically transfected human dendritic cells, their production and use, preferably as vaccines
10/30/1997	WO1997040180A1 Chicken embryo lethal orphan (celo) virus
10/30/1997	WO1997040177A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997	WO1997040176A1 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen
10/30/1997	WO1997040169A1 Non antibiotic selectable markers for live vaccines
10/30/1997	WO1997040167A1 Porcine retrovirus
10/30/1997	WO1997040166A2 Simian-human hav having a chimeric 2c protein
10/30/1997	WO1997040165A1 Novel human cytomegalovirus dna constructs and uses therefor
10/30/1997	WO1997040164A1 Hepatitis b monoclonal antibodies
10/30/1997	WO1997040163A1 Nucleic acid vaccination for parvoviral infections
10/30/1997	WO1997040161A1 Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
10/30/1997	WO1997040159A1 Characterization of transfer factors and methods of use
10/30/1997	WO1997040156A1 Mutated ras peptides for generation of cd8+ cytotoxic t lymphocytes
10/30/1997	WO1997040152A1 Glial cell line-derived neurotrophic factor receptor
10/30/1997	WO1997040147A1 Antigenically reactive regions of the hepatitis a virus polyprotein
10/30/1997	WO1997040143A1 Apoptosis inducing protein and gene encoding the same
10/30/1997	WO1997040140A1 Gd2 anti-idiotypic antibodies and uses thereof
10/30/1997	WO1997040073A2 BIOLOGICALLY ACTIVE PROTEIN (COLLAGEN FRAGMENT HF-COLL-18/514cf) FOR INHIBITING THE GROWTH OF TUMOURS AND CAPILLARY PROFILERATIONS
10/30/1997	WO1997040063A2 Pathogenic escherichia coli associated protein espa
10/30/1997	WO1997040058A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	WO1997039771A1 Heterologous boosting immunizations
10/30/1997	WO1997039762A1 Stabilized antihepatitis-b vaccine tablets
10/30/1997	WO1997039721A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	WO1997039698A1 Slow-release, self-absorbing, drug delivery system
10/30/1997	WO1997035997A3 Recombinant pox virus encoding myelin protein for therapy
10/30/1997	WO1997035989A3 Cyclic nucleotide phosphodiesterase
10/30/1997	WO1997035021A3 Prostate specific antigen oligo-epitope peptide
10/30/1997	WO1997025426A3 Compositions and methods for the treatment and diagnosis of breast cancer
10/30/1997	WO1997006255A3 Mammalian apoptosis inhibitor protein gene family, primers, probes and detection methods
10/30/1997	DE19616486A1 Verfahren zur Senkung des Blutglukosespiegels in Säugern A method for lowering blood glucose levels in mammals
10/30/1997	CA2285184A1 Stabilized antihepatitis-b vaccine tablets
10/30/1997	CA2252835A1 Chicken embryo lethal orphan (celo) virus
10/30/1997	CA2252643A1 Methods and compositions for regulating t cell subsets by modulating transcription factor activity
10/30/1997	CA2252581A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	CA2252439A1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
10/30/1997	CA2252406A1 Heterologous boosting immunizations
10/30/1997	CA2251977A1 Antigenically reactive regions of the hepatitis a virus polyprotein
10/30/1997	CA2251943A1 Characterization of transfer factors and methods of use
10/30/1997	CA2251939A1 Porcine retrovirus
10/30/1997	CA2251832A1 Simian-human hav having a chimeric 2c protein
10/29/1997	EP0803573A1 Polycistronic expression construct with cytokines for multivalent vaccines
10/29/1997	EP0803511A1 Allergenic proteins from ragweed and uses therefor
10/29/1997	EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997	EP0802983A2 Expression of urokinase plasminogen activator inhibitors
10/29/1997	EP0802980A1 Nucleic acid immunization using a virus-based infection/transfection system
10/29/1997	EP0802979A1 Secreted viral proteins useful for vaccines and diagnostics
10/29/1997	EP0802924A1 Antibodies against t-cells as therapeutics
10/29/1997	EP0802797A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
10/29/1997	EP0802796A1 Chicken anaemia agent broiler vaccine
10/29/1997	EP0672063B1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1997	EP0573435B1 Acellular vaccine
10/29/1997	EP0116571B2 Method for making gamma globulin-containing compositions
10/29/1997	CN1163619A Antigenic polypeptide of chlamydia pneumoniae
10/29/1997	CN1163575A Immunogenic compositions
10/29/1997	CN1163102A Container with freeze-dried vaccine component
10/28/1997	US5681942 Fanconi Anemia Type C gene
10/28/1997	US5681934 47-kilodalton antigen of Treponema pallidum
10/28/1997	US5681724 Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof
10/28/1997	US5681713 Genetic engineering
10/28/1997	US5681571 Immunological tolerance-inducing agent
10/28/1997	US5681568 Device for delivery of substances and methods of use thereof
10/28/1997	US5681565 Coating with immunoglobulins, antibodies
10/28/1997	US5681562 Lymphokine gene therapy of cancer
10/28/1997	US5681556 Method and compositions for suppressing allograft rejection in mammals
10/28/1997	CA1339515C Diagnostic system for the detection of cytomegalovirus
10/23/1997	WO1997039134A1 Virus-like particle
10/23/1997	WO1997039119A1 Mammalian genes involved in viral infection and tumor suppression
10/23/1997	WO1997039034A1 Means for detecting bacteria of the taylorella equigenitalis species and their biological applications
10/23/1997	WO1997039029A2 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
10/23/1997	WO1997039022A1 Novel compounds
10/23/1997	WO1997039021A1 Targeted therapeutic or diagnostic agents and methods of making and using same
10/23/1997	WO1997039020A2 Antigenic sequences of a sperm protein and immunocontraceptive methods
10/23/1997	WO1997039017A1 STREPTOCOCCUS PNEUMONIAE HISTIDYL tRNA SYNTHETASE
10/23/1997	WO1997039016A1 NOVEL LysS PROTEINS FROM STREPTOCOCCUS PNEUMONIAE
10/23/1997	WO1997039015A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE
10/23/1997	WO1997039014A1 STREPTOCOCCUS PNEUMONIAE ASPARTYL tRNA SYNTHETASE
10/23/1997	WO1997039013A1 STREPTOCOCCUS PNEUMONIAE ALANYL tRNA SYNTHETASE
10/23/1997	WO1997039012A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
10/23/1997	WO1997039011A1 STREPTOCOCCUS PNEUMONIAE ISOLEUCYL tRNA SYNTHETASE
10/23/1997	WO1997038731A1 Immunoliposomes that optimize internalization into target cells
10/23/1997	WO1997038725A1 Methods of delaying development of cea-associated tumors using anti-idiotype antibody 3h1
10/23/1997	WO1997038724A1 New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
10/23/1997	WO1997038722A1 Novel compounds
10/23/1997	WO1997038721A1 Novel compounds
10/23/1997	WO1997038720A1 Novel compounds
10/23/1997	WO1997038719A1 Novel compounds
10/23/1997	WO1997038718A1 Novel compounds
10/23/1997	WO1997038717A1 Novel compounds
10/23/1997	WO1997038716A1 Novel compounds
10/23/1997	WO1997038715A1 Novel compounds
10/23/1997	WO1997038714A1 Novel compounds
10/23/1997	WO1997038713A1 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone h1
10/23/1997	WO1997038711A2 T-cell dependent vaccine and the cell surface receptor cd28
10/23/1997	WO1997038708A1 Modulating epithelial-mesenchymal interactions
10/23/1997	WO1997038695A1 Dhea combination therapy
10/23/1997	WO1997038689A2 Enteric-coated pharmaceutical compositions of mycophenolate

1 ... 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 ... 1823